Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about age/related macular degeneration

Recent news which mentions age/related macular degeneration

Opthea Shares OPT-302 data In Patients With Subtype Of Age-Related Macular Degeneration
Tickers OPT
Tags OPT Briefs Market News
From Benzinga
Viteyes Focuses on Eye Health Nutrition during Age-Related Macular Degeneration (AMD) Awareness Month
Tickers AMD
Tags Age/related Macular Degeneration Michigan AREDS 2
From PRLog
FDA Approves First Injectable Eye Medicine For Vision Loss Disorder - Genentech's Vabysmo
Tickers RHHBF RHHBY RHHVF
Tags General News Health Care
From Benzinga
Adverum Outlines Development Plan For ADVM-022 Gene Therapy In Wet AMD
Tickers ADVM
Tags Penny Stocks ADVM Briefs
From Benzinga
Lineage, Genentech Ink Cell Therapy Licensing Pact For Ocular Diseases
Tickers LCTX RHHBF RHHBY RHHVF
Tags Market News Benzinga Long Ideas
From Benzinga
Eyecheck Sets Scientific Standard for Premium Ocular Health Supplements
Tickers AMD
Tags Health & Fitness Eye Health Wellness
From PRUnderground
Why Are EyePoint Shares Trading Higher Today?
Tickers EYPT
Tags why it's moving EYPT Small Cap
From Benzinga
Why Did Mizuho Upgrade This Biotech Stock Focused On Age-Related Eye Diseases?
Tickers UBX
Tags Penny Stocks Briefs Upgrades
From Benzinga
4D Molecular To Test Its Wet AMD Gene Therapy In Patients
Tickers FDMT
Tags Movers News General
From Benzinga
Unity Biotechnology Stock Falls After Updated Data From Wet AMD Candidate
Tickers UBX
Tags Briefs Penny Stocks Movers
From Benzinga
Graybug Vision Posts Six-Month Extension GB-102 Data Of Wet AMD Trial
Tickers GRAY REGN
Tags Biotech Market News Benzinga
From Benzinga
AbbVie, RegenXBio Ink $1.75B Retinal Gene Therapy Collaboration
Tickers ABBV RGNX
Tags Trading Ideas Biotech Market News
From Benzinga
Regeneron Touts Mid-Stage Win For Higher Dose Of Eylea In Age-related Macular Degeneration
Tickers BAYRY BAYZF REGN
Tags BAYRY Biotech Market News
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.